Evangelos Dimakakos
Overview
Explore the profile of Evangelos Dimakakos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
595
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Patriarcheas V, Tsamos G, Vasdeki D, Kotteas E, Kollias A, Nikas D, et al.
J Clin Med
. 2025 Feb;
14(3).
PMID: 39941405
: Antiphospholipid syndrome (APS) is a rare systemic autoimmune disease characterized by persistent antiphospholipid antibodies (aPL) in combination with recurrent thrombosis in the veins and/or arteries, obstetric morbidity, and various...
2.
Vasdeki D, Tsamos G, Dimakakos E, Patriarcheas V, Koufakis T, Kotsa K, et al.
Nutrients
. 2024 Nov;
16(21).
PMID: 39519484
As the incidence of type 2 diabetes mellitus (T2DM) continues to increase globally, researchers are keen to investigate various interventions to mitigate its impact. Among these, vitamin D supplementation has...
3.
Kouvela M, Livanou M, Stefanou D, Vathiotis I, Sarropoulou F, Grammoustianou M, et al.
Cancers (Basel)
. 2024 Apr;
16(7).
PMID: 38611118
Background: The aim of this study was to record and assess the efficacy and safety ofthromboprophylaxis with an intermediate dose of Tinzaparin in lung cancer patients with high thrombotic risk....
4.
Pillon S, Gomatou G, Dimakakos E, Stanek A, Pecsvarady Z, Kozak M, et al.
J Clin Med
. 2024 Mar;
13(6).
PMID: 38541976
Telemedicine is increasingly used in several fields of healthcare, including vascular medicine. This study aimed to investigate the views of experts and propose clinical practice recommendations on the possible applications...
5.
Vasilakaki S, Vathiotis I, Panagiotou E, Dimakakos E, Gomatou G, Kotteas E
Immunotherapy
. 2023 Dec;
16(1):21-28.
PMID: 38054258
To compare the protein-protein interactions of antibodies targeting PD-1 and its ligand (PD-L1) with their targets in an attempt to explain the antibodies' binding affinity. The structural features of complexes...
6.
Dapergola A, Gomatou G, Trontzas I, Panagiotou E, Dimakakos E, Syrigos N, et al.
Oncol Lett
. 2023 Feb;
25(2):84.
PMID: 36760515
Thymic epithelial tumors (TETs), including thymomas and thymic carcinomas, are rare malignancies arising from the thymus gland. The optimal management requires a multidisciplinary approach. Standard first-line systemic treatment involves cytotoxic...
7.
Kollias A, Kyriakoulis K, Dimakakos E
JAMA Intern Med
. 2022 Dec;
183(2):168-169.
PMID: 36534390
No abstract available.
8.
Kyriakoulis K, Dimakakos E, Kyriakoulis I, Catalano M, Spyropoulos A, Schulman S, et al.
J Clin Med
. 2022 Oct;
11(20).
PMID: 36294316
Coronavirus disease 2019 (COVID-19) has been shown to be strongly associated with increased risk for venous thromboembolism events (VTE) mainly in the inpatient but also in the outpatient setting. Pharmacologic...
9.
Dimakakos E, Gomatou G, Catalano M, Olinic D, Spyropoulos A, Falanga A, et al.
Anticancer Res
. 2022 Jul;
42(7):3261-3274.
PMID: 35790272
Cancer and COVID-19 are both well-established risk factors predisposing to thrombosis. Both disease entities are correlated with increased incidence of venous thrombotic events through multifaceted pathogenic mechanisms involving the interaction...
10.
Wautrecht J, Olinic D, Catalano M, Baines C, Belch J, Blinc A, et al.
Int Angiol
. 2022 Apr;
41(3):258-274.
PMID: 35373943
No abstract available.